未登录

A

Andy Nong

Health Canada

H指数:29

被引数:2,549

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Novel Automated Micro Solid Phase Extraction (µSPE) Method to Quantify 21 Per- and Polyfluoroalkyl Substances Compounds in Biological Samples

Advances in Sample Preparation

IF6.5

2026-01-300

OAAI

Applying New Approach Methods for Toxicokinetics for Chemical Risk Assessment

应用新的毒代动力学方法进行化学风险评价

Chemical Research in Toxicology

IF3.8

2025-07-220

PRE

Animal-free assessment of developmental toxicity: Combining PBPK modeling with the ReproTracker assay

发育毒性的无动物评估: 将PBPK建模与ReproTracker测定相结合

IF4.6

2023-12-013

OAAI

Mining toxicogenomic data for dose-responsive pathways: implications in advancing next-generation risk assessment

挖掘剂量反应途径的毒理基因组学数据: 对推进下一代风险评估的意义

FRONTIERS IN TOXICOLOGY

IF4.6

2023-11-172

OAAI

Towards translating in vitro measures of thyroid hormone system disruption to in vivo responses in the pregnant rat via a biologically based dose response (BBDR) model

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2023-11-014

PRE

Toxicokinetics of praseodymium and cerium administered as chloride salts in Sprague-Dawley rats: impacts of the dose and of co-exposure with additional rare earth elements

ARCHIVES OF TOXICOLOGY

IF6.9

2023-09-070

PRE

Biomonitoring Equivalents for Molybdenum (vol 77, pg 223, 2016)

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2022-10-010

PRE

Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application

ARCHIVES OF TOXICOLOGY

IF6.9

2022-04-2114

OAAI

Insights into ultrasound-promoted degradation of naphthenic acid compounds in oil sands process affected water. Part II: In silico quantum screening of hydroxyl radical initiated and propagated degradation of benzoic acid

ULTRASONICS SONOCHEMISTRY

IF9.7

2022-04-013

OAAI

Toxicokinetics in rats and modeling to support the interpretation of biomonitoring data for rare-earth elements

ENVIRONMENT INTERNATIONAL

IF9.7

2021-10-0112

OAAI

Derivation of Biomonitoring Equivalents for aluminium for the interpretation of population-level biomonitoring data

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2021-06-015

OAAI

High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization

TOXICOLOGICAL SCIENCES

IF4.1

2021-03-2769

OAAI

Estimation of toluene exposure in air from BMA (S-benzylmercapturic acid) urinary measures using a reverse dosimetry approach based on physiologically pharmacokinetic modeling

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2021-03-012

PREAI

Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2020-07-019

OAAI

Derivation of biomonitoring equivalents (BE values) for bismuth

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2020-07-012

OAAI

Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2020-03-014

OAAI

Evaluating hexabromocyclododecane (HBCD) toxicokinetics in humans and rodents by physiologically based pharmacokinetic modeling

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2019-11-019

PREAI

Hexabromocyclododecane (HBCD): A case study applying tiered testing for human health risk assessment

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2019-09-0121

OAAI

Development of Biomonitoring Equivalents for chlordane and toxaphene with application to the general Canadian population

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2019-08-0111

PREAI

Biomonitoring Equivalents for interpretation of urinary iodine

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2018-04-0111

OAAI